By amalgamating existing literature on the role of Phytomolecules as modulators of the NRF2 pathway in managing liver diseases through the adoption of scoping review methodology, this study distinguishes itself and contributes novel evidence to the field. The gene discussed is NFE2L2; the disease is liver disorder.